SCHEMBL19183191

SCHEMBL19183191

C=Cc1ccc(/C=C/O/C=C/c2ccc(C=C)cc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.58
TSHR P16473 2/20 0.43
TDP1 Q9NUW8 3/20 0.38
HDAC8 Q9BY41 1/20 0.37
TRPA1 O75762 2/20 0.33
CHRNB2 P17787 1/20 0.33
CHRNB4 P30926 1/20 0.33
CHRNA3 P32297 1/20 0.33
CHRNA7 P36544 1/20 0.33
CHRNA4 P43681 1/20 0.33
TP53 P04637 4/20 0.31
KDM4E B2RXH2 3/20 0.31
LMNA P02545 3/20 0.31
CYP3A4 P08684 3/20 0.31
CA12 O43570 2/20 0.31
CA1 P00915 2/20 0.31
CA2 P00918 2/20 0.31
CA3 P07451 2/20 0.31
CA4 P22748 2/20 0.31
CA6 P23280 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11712083 1.00 ALDH1A1 (0.58) ALDH1A1TSHRTDP1HDAC8TRPA1
SCHEMBL3113833 0.80 ALDH1A1 (0.79) ALDH1A1TSHRTDP1HDAC8TP53
SCHEMBL3113837 0.80 ALDH1A1 (0.79) ALDH1A1TSHRTDP1HDAC8TP53
SCHEMBL7639 0.76 ALDH1A1 (1.00) ALDH1A1TSHRTDP1HDAC8TRPA1
SCHEMBL473081 0.76 ALDH1A1 (1.00) ALDH1A1TSHRTDP1HDAC8TRPA1
Vinyl Ether SCHEMBL4783184 0.75 ALDH1A1 (0.69) ALDH1A1TSHRTDP1HDAC8TRPA1
SCHEMBL6901265 0.74 APP (0.58) ALDH1A1TDP1TRPA1TP53KDM4E
SCHEMBL8321726 0.74 AHR (0.52) ALDH1A1HDAC8KDM4ELMNACYP1A2
SCHEMBL15514187 0.74 APP (0.56) ALDH1A1TSHRTDP1CYP3A4MEN1
SCHEMBL757522 0.74 RELA (0.54) ALDH1A1TDP1CYP3A4CA1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10730990-B2 Graphene oxide modified thermoset monomer and synthesis thereof CONTINENTAL STRUCTURAL PLASTICS, INC. (US) 2020-08-04 US disclosed
US-20190031808-A1 GRAPHENE OXIDE MODIFIED THERMOSET MONOMER AND SYNTHESIS THEREOF CSP INNOVATIONS, INC. 2019-01-31 US disclosed
WO-2017132156-A1 GRAPHENE OXIDE MODIFIED THERMOSET MONOMER AND SYNTHESIS THEREOF CONTINENTAL STRUCTURAL PLASTICS, INC. (US) 2017-08-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190031808-A1 GRAPHENE OXIDE MODIFIED THERMOSET MONOMER AND SYNTHESIS THEREOF GMNN, GIGYF2, ALG8 ALDH1A1 1247/4885TSHR 4697/4885TDP1 3858/4885
US-10730990-B2 Graphene oxide modified thermoset monomer and synthesis thereof GMNN, GIGYF2, ALG8 ALDH1A1 1247/4885TSHR 4697/4885TDP1 3858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.